Consultation worksheet
Start with the decision in front of you. Work through the sections, then build a consultation note that another clinician could follow. Deferring PRP, addressing another diagnosis and arranging referral are legitimate outcomes. Nothing here is scored.
QG3Patient and clinical problem
QG3Safety review
QG3Expected benefit and limitations
QG4Put PRP beside the alternatives
Compare options against the same patient goal. Several may be used together. Tick each option you discussed.
| Option | Decision it helps address | Discuss or document |
|---|
QG5Shared decision and teach back
Use the patient's goal to anchor the conversation. Check understanding before asking for consent.
“We are considering whether this treatment might improve your pain and function. We cannot promise that it will rebuild cartilage or prevent a future joint replacement.”
“PRP preparations and study results vary. Improvement is possible, but some people obtain no useful benefit. We should compare the options that fit your situation.”
Teach back — the patient explained, in their own words:
Patient's choice
QG6Medication and procedure plan
Resolve uncertainty before collection. A medicine list and a signed consent form do not by themselves establish readiness.
| Issue | Record | Decision rule |
|---|
QG3Decision
Handover to rehabilitation (QG11, optional)
Basis: practice framework; QG3–QG6 and QG11; Chapters 7–13 and 15; sources Q1, Q2 and Q6. Use locally approved consent materials.
Characterize what was administered
An interpretable outcome requires a traceable product and procedure. Use measured values where available. Mark unmeasured characteristics unknown; do not substitute a kit's marketing claim.
QG7Dose arithmetic
PlanExpected yield before preparation
An estimate for planning the draw, made before any product exists. It depends entirely on the recovery rate you enter, so use your own device's measured recovery. After preparation, record the measured counts above; this estimate does not replace them.
A3Product and procedure record
Basis: product documentation framework; QG7 and A3; Chapters 3, 4, 11 and 12; source Q5. Arithmetic only; no dose or recovery target. Recovery and course-total calculations and the expected-yield estimate added 1 October 2026. Numerical preparation settings must come from the applicable validated process and manufacturer instructions.
Track outcomes that change the plan
Choose a validated measure appropriate to the joint. Record its version, scoring direction and assessment conditions, and use the same measure over time. Declare the meaningful-change criterion and its source before the result is known.
QG8Measure and criterion
| Measure | Baseline | Review 1 | Review 2 |
|---|
QG9What pattern do you and the patient see?
Classify together. Select the row that fits; the right-hand box shows the next step from the reassessment pathway.
Before any repeat course
Previous improvement is information, not proof that a repeat course will reproduce it.
Basis: author-designed reassessment pathway and practice framework; QG8–QG9 and S4; Chapters 6, 7, 9, 10 and 13; source Q3. Repeat-treatment timing and selection remain uncertain.
Safety and aftercare triage
Severe or progressive symptoms require assessment whenever they occur. Neither early onset nor absence of fever excludes infection. Tick what the patient reports; the highest level of response is shown.
QG10Give the patient a route to help
These details are also copied into patient page B2. Explain where to go if the clinic cannot be reached.
Basis: source Q4 for suspected septic arthritis; Chapters 12–13 for PRP aftercare; QG10, S4 and B2.
Branching teaching cases
Eight composite teaching examples from Appendix E. Choose a first decision, read the reasoning, then work through the new information and the branches. Your answers are not saved.
Preferred first decisions: 0 of 0 attempted
High-level summary tables
For rapid orientation before a consultation or clinical huddle. A concern in the right-hand column does not label the patient as unsuitable; it identifies the next question, support or assessment needed.
Evidence labels
Labels identify the basis of advice. They are editorial labels, not a new grading system. Apply them to individual claims.
| Label | Meaning |
|---|
Sources for the clinic tools
Tools reviewed on 16 September 2026. The book's chapters retain their own numbered bibliographies.
Patient pages
Personalize each page, confirm understanding, then print it. Use your applicable consent process. Contact details entered on the Safety triage tab are copied into B2.
B1 · Patient information to discuss with your healthcare professional
PRP: making your treatment choice
What is PRP?
Platelet-rich plasma is prepared from a sample of your blood and injected into the treatment area. Preparations differ. Your clinician should explain the product and procedure being proposed.
What might it do?
Some patients report less pain or better function, but useful benefit is not guaranteed. PRP has not been established as a way to rebuild your joint cartilage, cure osteoarthritis or prevent a future joint replacement.
What are the alternatives?
Depending on your situation, options may include education, tailored exercise, weight-management support, medicines, another injection or specialist assessment. Ask how each option fits the activity you want to improve.
What should I understand before deciding?
Ask about pain or swelling after treatment, bruising, bleeding, infection and other risks relevant to you. Discuss your medicines, planned rehabilitation, follow-up and who to contact if symptoms concern you.
Your decision record
Check your understanding
Can you explain what PRP might help, what it cannot promise, and which alternatives you could choose? You may ask for more time before deciding.
B2 · Keep this page with your individual aftercare plan
After PRP: your plan and when to get help
Medicines
Follow the written plan from your treating team. Do not stop prescribed aspirin, blood thinners or other medicines on your own. Ask the team if the instructions are unclear or your pain relief is inadequate.
Activity
Follow the activity and rehabilitation plan agreed for you. Ask when and how to increase activity. A fixed calendar cannot account for every patient's symptoms and function.
Get urgent assessment at any time
Seek urgent help for severe or increasing pain, a hot swollen joint, inability to bear weight, fever or shaking chills, spreading redness or discharge. These symptoms need assessment even on the first day. No fever does not mean there is no infection. Do not wait until a routine follow-up appointment.
For collapse, breathing difficulty or other emergency symptoms, contact local emergency services. If you cannot reach your clinic about urgent joint symptoms, use the urgent-care route below.
If the treatment does not help
Tell the team at review, or sooner if symptoms worsen. The next step should include reassessment and discussion of alternatives. Another injection is not an automatic next step.
Your contacts and review
About this companion
This is the free clinic companion to Biologic Joint Preservation: The Clinical Guide to PRP in Osteoarthritis — Science, Evidence, Controversy, and Patient-Centered Practice by Dr. Hafez Selim, MD, PhD, Dr. Abir Hegazy, MB BCh, MSc (PM&R), and Gana Sharafeldin, MB BCh BAO (Selim Medical Press). It turns the book's Clinic Quick Guide (QG1–QG12), High-Level Summary Tables (S1–S4), procedure forms (Appendix A), patient pages (Appendix B) and branching cases (Appendix E) into working screens.
| Screen | Book source |
|---|---|
| Consultation | QG3 selection worksheet, QG4 alternatives, QG5 shared decision, QG6 medication and procedure plan, QG11 consultation note and handover |
| Product & dose | QG7 minimum record and dose arithmetic; A3 product and procedure record |
| Review & next step | QG8 outcome tracking; QG9 nonresponse and repeat-treatment pathway; S4 |
| Safety triage | QG10 safety and aftercare triage; A4 and B2 safety wording |
| Teaching cases | Appendix E, cases E1–E8 |
| At a glance | S1–S4; QG12 evidence labels and sources Q1–Q6 |
| Patient pages | Appendix B, pages B1–B2 |
It runs entirely in your browser. There are no analytics, no tracking, no cookies and no network requests. Nothing you type is stored or transmitted, and reloading the page discards everything. Do not enter identifiable patient information.
The companion to the authors' earlier textbook, Platelet-Rich Plasma for Degenerative Osteoarthritis, remains available at abdu94-hash.github.io/prp-oa-tool, with a candidacy screener and an evidence explorer.
Tools reviewed: 16 September 2026. Guideline positions, regulatory provisions, coverage determinations and device instructions change. Re-verify before relying on anything here.